- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-5076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer ; volume:14 ; number:3 ; day:29 ; month:6 ; year:2021 ; pages:247-251 ; date:9.2021
Magazine of European Medical Oncology ; 14, Heft 3 (29.6.2021), 247-251, 9.2021
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-021-00722-4
- URN
-
urn:nbn:de:101:1-2021112708364575831467
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartsch, Rupert
- SpringerLink (Online service)
Other Objects (12)
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Metastatic Triple-Negative Breast Cancer
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Metastatic Triple-Negative Breast Cancer
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Metastatic Triple-Negative Breast Cancer
Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers
How We Treat HER2-Positive Metastatic Breast Cancer
ASCO 2018: highlights in HER2-positive metastatic breast cancer
ASCO 2019: highlights in HER2-positive metastatic breast cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Deep-learning based discrimination of pathologic complete response using MRI in HER2-positive and triple-negative breast cancer
Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
New Systemic Therapy Strategies for HER2-Positive Metastatic Breast Carcinoma
Current Standards and Future Outlooks in Metastatic Her2-Positive Breast Cancer